Drug major Dr Reddy's Laboratories on Friday said it has received shareholders nod for proposed amalgamation of Dr Reddy's Holdings Ltd into the company.
The resolution for the scheme was approved by 99.98 per cent votes of the total 13.10 crore votes casted by equity shareholders of the company, it said in a regulatory filing.
21,026 votes, which accounted for the rest 0.02 per cent, were posted against the resolution, it added.
The voting was conducted as per the directions of the Hyderabad Bench of the National Company Law Tribunal on November 22, 2019.
The meeting of equity shareholders was convened on January 2, 2020.
The board of Dr Reddy's Laboratories had on July 29, 2019, approved the amalgamation of Dr Reddy's Holdings Ltd, an entity held by the promoter group which holds 24.88 per cent equity shares of Dr Reddy's Laboratories, into the company.
The scheme would lead to simplification of the shareholding structure and reduction of shareholding tiers, the company had said.
"The Promoter Group cumulatively will continue to hold the same number of shares in the Company, pre and post the amalgamation," it had said.
Shares of Dr Reddy's Laboratories on Friday settled at Rs 2,888.90 on the BSE, up 0.87 per cent from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)